Army signs off on two-year biodefense readiness restructuring
The Army has approved a two-year plan to revamp its approach to biological warfare readiness. Lt. Gen. Brian Eifler, the service's deputy chief of staff for operations, signed off on the 2026 Biodefense Strategy implementation plan in early October. The effort is backed by roughly $2 million in annual targeted funding and is driven in part by concerns that artificial intelligence could make biological weapons easier to access and more dangerous.
The Army's deputy chief of staff for operations, Lt. Gen. Brian Eifler, gave the go-ahead in early October for a 2026 implementation plan tied to the service's biodefense strategy. The plan sets a two-year course for altering how the Army prepares for biological threats.
About $2 million in targeted funds is expected each year to support the effort. One stated concern is that artificial intelligence may lower barriers to obtaining biological weapons and raise the danger they pose.
The Army's two-year biodefense effort could affect soldiers, defense planners, and civilian emergency and public health partners by changing how biological threats are anticipated and addressed. If the plan leads to updated training, equipment, or coordination, communities near military installations may see shifts in preparedness activities. The focus on artificial intelligence may also shape future discussions about oversight, funding, and risk assessment, though the plan's roughly $2 million annual backing suggests a targeted rather than sweeping initial effort.